Table V.
Clinical diagnosis, sample size and age distribution of participants with gene mutations affecting the Ras/MAPK signaling pathway
Clinical diagnosis | Gene | n | Age range | Mean age |
---|---|---|---|---|
Noonan syndrome | ||||
PTPN11 | 50 | 1.0–24.5 | 7.6 | |
SOS1 | 11 | 3.2–16.9 | 10.3 | |
RAF1 | 3 | 1.7–9.8 | 4.8 | |
KRAS | 2 | 1.4–3.8 | 2.6 | |
BRAF | 1 | 14.3 | 14.3 | |
CFC syndrome | ||||
BRAF | 19 | 1.1–21.6 | 9.1 | |
MEK1 | 1 | 9.8 | 9.8 | |
MEK2 | 2 | 10.4–14.3 | 12.3 |